This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Rapid Plasma Reagin Test Market

Market Insights on Rapid Plasma Reagin Test covering sales outlook, demand forecast & up-to-date key trends

Rapid Plasma Reagin Test Market by Product Type, Disease, End User & Region - Forecast 2022 - 2032

Rapid Plasma Reagin Test Market Outlook

The rapid plasma reagin test market is likely to register a CAGR of 4% during the forecast period, and is anticipated to reach a market share of US$ 68.51 Mn in 2032, from US$ 46.28 Mn in 2022, owing to the growing demand for the rapid testing to reduce time consumption and need of instruments.

Attributes

Details

Rapid Plasma Reagin Test Market CAGR

4%

Rapid Plasma Reagin Test Market Size (2022)

US$ 46.28 Mn

Rapid Plasma Reagin Test Market Size (2032)

US$ 68.51 Mn

One of the most common sexually transmitted infections is syphilis. According to the World Health Organisation, around 5.6 million new cases of syphilis were reported worldwide in 2012 among adults and adolescents aged 15 to 49. This is one of the major factors for higher sales of rapid plasma reagin test.

The demand for rapid plasma reagin tests for early detection is increasing as a result of growing and non-profit organizations' initiatives to alleviate the burden of sexually transmitted illnesses. Syphilis can be cured if caught early enough; this emphasizes the need for accurate and prompt diagnosis, which results in urgent demand for rapid plasma reagin test.

The rapid plasma reagin test market is being driven by an increase in the prevalence of syphilis, increased awareness of sexually transmitted diseases, technical advancements. Introduction of new products enhancing the sales of rapid plasma reagin test kits.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Wins in the Rapid Plasma Reagin Test Market

The most common factor driving demand for rapid plasma reagin test solutions is the rising frequency of syphilis. The rapid plasma reagin test market is expected to develop due to rising demand for screening pregnant women for syphilis prevention in their children.

The sales of rapid plasma reagin test is growing due to rising demand for rapid testing to save time and reduce the requirement for instruments. The rapid plasma reagin test market is predicted to increase as a result of technological advancements and the introduction of new products.

The sales of rapid plasma reagin test is predicted to rise due to an increase in the number of healthcare testing programs and awareness campaigns for sexually transmitted diseases.

What are the Milestones in the Rapid Plasma Reagin Test Market

Low reimbursement rates for rapid plasma reagin test procedures are projected to limit the demand for rapid plasma reagin tests. In addition, limited awareness of sexually transmitted infections in the population of low and middle-income countries is projected to stymie the sales of rapid plasma reagin test kits.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Regional Outlook of the Rapid Plasma Reagin Test Market

Due to the increased use of new technologies and rapid test kits for syphilis testing, North America is likely to lead the rapid plasma reagin test market. As laboratory-based rapid testing demand for sexually transmitted infection grows, Europe is predicted to generate the second-highest rapid plasma reagin test market revenue share in the rapid plasma reagin test.

The Asia Pacific rapid plasma reagin test market share is predicted to grow at a faster rate due to increased sexually transmitted infection (STI) awareness efforts and the rising prevalence of STI illnesses.

As a result of increased awareness of sexually transmitted infections (STIs) and government programs for diagnostic testing, Asian countries such as India and China are predicted to develop at the fastest rate, with the higher sales of rapid plasma reagin test over the forecast period.

How Competition Influences the Rapid Plasma Reagin Test Market

Some market participants in the global rapid plasma reagin test market across the value chain are Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Beckman Coulter Inc (Danaher Corporation), Abbott Laboratories, Siemens AG, Sekisui Diagnostics, Immunostics Inc., Cardinal Health, Inc., Sclavo Diagnostics International, Novacyt Group, Meridian Bioscience Inc., Arlington Scientific, Inc., Bio-Rad Laboratories, Inc. and other companies. With novel product formulations and launches, these prominent industry players are expected to boost rapid plasma reagin test market share growth.

  • Market competitors in the rapid plasma reagin test are working on releasing new products and kits that will allow them to test with more precision, and contribute to the greater sales of the rapid plasma reagin test. For example, Arlington Scientific Inc. received FDA approval for its ChemWell RPR automated analyzer for cost-effective syphilis diagnosis in September 2019.
  • Rapid plasma reagin tests for early detection are in high demand due to the rising frequency of sexually transmitted infections (STIs) and growing awareness campaigns. The introduction of a novel diagnostic approach has influenced the rapid plasma reagin test market's growth.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth rate

CAGR of 4% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Product type, design type, end use, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

Thermo Fisher Scientific, F. Hoffmann-La Roche AG,  Beckman Coulter Inc (Danaher Corporation), Abbott Laboratories, Siemens AG, Sekisui Diagnostics, Immunostics Inc., Cardinal Health, Inc., Sclavo Diagnostics International, Novacyt Group, Meridian Bioscience Inc., Arlington Scientific, Inc., Bio-Rad Laboratories, Inc. and other companies

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The rapid plasma reagin test market is anticipated to register a CAGR of 4% during the forecast period.

The rapid plasma reagin test market share is anticipated to reach US$ 68.51 Mn in 2032.

Demand for the rapid plasma reagin test market is likely to rise, growing demand for the rapid testing to reduce time consumption and need of instruments.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cardiolipin Antibodies Test Market

Published : October 2019

Healthcare

Cryptococcal Antigen Lateral Flow Assay Test Market

Published : February 2016

Healthcare

Blood Culture Test Market

Published : January 2016

Healthcare

Thyroid Function Tests Market

Published : January 1970

Google translate

Rapid Plasma Reagin Test Market